Selected research
Market Outlook & Growth Opportunities
Global Drug and Medical Device Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Drug and Medical Device Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Drug and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Drug and Medical Device Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Drug and Medical Device Testing market include SGS, Beijing Pony Testing Company, GTTC, Shanghai International Certification Assessment Services Co.,Ltd., Guangdong Sino-sci Testing Technology Corporation Limited, GBT, FUDA TESTING GROUP, Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. and Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Drug and Medical Device Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug and Medical Device Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug and Medical Device Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug and Medical Device Testing market.
Drug and Medical Device Testing Segment by Company
SGS
Beijing Pony Testing Company
GTTC
Shanghai International Certification Assessment Services Co.,Ltd.
Guangdong Sino-sci Testing Technology Corporation Limited
GBT
FUDA TESTING GROUP
Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
Guangzhou Medicine Industry Research Institute
Drug and Medical Device Testing Segment by Type
Drug Testing
Medical Device Testing
Drug and Medical Device Testing Segment by Application
Pharmaceutical Products Manufacturer
Medical Device Manufacturer
Drug and Medical Device Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Drug and Medical Device Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drug and Medical Device Testing key companies, revenue, market share, and recent developments.
3. To split the Drug and Medical Device Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drug and Medical Device Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drug and Medical Device Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Drug and Medical Device Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug and Medical Device Testing industry.
Chapter 3: Detailed analysis of Drug and Medical Device Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drug and Medical Device Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drug and Medical Device Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Drug and Medical Device Testing Industry Trends
Table 2. Drug and Medical Device Testing Industry Drivers
Table 3. Drug and Medical Device Testing Industry Opportunities and Challenges
Table 4. Drug and Medical Device Testing Industry Restraints
Table 5. Global Drug and Medical Device Testing Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Drug and Medical Device Testing Revenue Share by Company (2021-2026)
Table 7. Global Drug and Medical Device Testing Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Drug and Medical Device Testing Key Company Manufacturing Base & Headquarters
Table 9. Global Drug and Medical Device Testing Company, Product Type & Application
Table 10. Global Drug and Medical Device Testing Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drug and Medical Device Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Drug Testing
Table 15. Significant Companies of Medical Device Testing
Table 16. Global Drug and Medical Device Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Drug and Medical Device Testing Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Drug and Medical Device Testing Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Drug and Medical Device Testing Sales Value Share by Type (2021-2026)
Table 20. Global Drug and Medical Device Testing Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Pharmaceutical Products Manufacturer
Table 22. Significant Companies of Medical Device Manufacturer
Table 23. Global Drug and Medical Device Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 24. Global Drug and Medical Device Testing Sales Value by Application (2021-2026) & (US$ Million)
Table 25. Global Drug and Medical Device Testing Sales Value by Application (2027-2032) & (US$ Million)
Table 26. Global Drug and Medical Device Testing Sales Value Share by Application (2021-2026)
Table 27. Global Drug and Medical Device Testing Sales Value Share by Application (2027-2032)
Table 28. Global Drug and Medical Device Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Drug and Medical Device Testing Sales Value by Region (2021-2026) & (US$ Million)
Table 30. Global Drug and Medical Device Testing Sales Value Share by Region (2021-2026)
Table 31. Global Drug and Medical Device Testing Sales Value by Region (2027-2032) & (US$ Million)
Table 32. Global Drug and Medical Device Testing Sales Value Share by Region (2027-2032)
Table 33. Global Drug and Medical Device Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Drug and Medical Device Testing Sales Value by Country (2021-2026) & (US$ Million)
Table 35. Global Drug and Medical Device Testing Sales Value Market Share by Country (2021-2026)
Table 36. Global Drug and Medical Device Testing Sales Value by Country (2027-2032) & (US$ Million)
Table 37. Global Drug and Medical Device Testing Sales Value Market Share by Country (2027-2032)
Table 38. SGS Company Information
Table 39. SGS Business Overview
Table 40. SGS Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 41. SGS Drug and Medical Device Testing Product Portfolio
Table 42. SGS Recent Development
Table 43. Beijing Pony Testing Company Company Information
Table 44. Beijing Pony Testing Company Business Overview
Table 45. Beijing Pony Testing Company Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. Beijing Pony Testing Company Drug and Medical Device Testing Product Portfolio
Table 47. Beijing Pony Testing Company Recent Development
Table 48. GTTC Company Information
Table 49. GTTC Business Overview
Table 50. GTTC Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. GTTC Drug and Medical Device Testing Product Portfolio
Table 52. GTTC Recent Development
Table 53. Shanghai International Certification Assessment Services Co.,Ltd. Company Information
Table 54. Shanghai International Certification Assessment Services Co.,Ltd. Business Overview
Table 55. Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
Table 57. Shanghai International Certification Assessment Services Co.,Ltd. Recent Development
Table 58. Guangdong Sino-sci Testing Technology Corporation Limited Company Information
Table 59. Guangdong Sino-sci Testing Technology Corporation Limited Business Overview
Table 60. Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Product Portfolio
Table 62. Guangdong Sino-sci Testing Technology Corporation Limited Recent Development
Table 63. GBT Company Information
Table 64. GBT Business Overview
Table 65. GBT Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. GBT Drug and Medical Device Testing Product Portfolio
Table 67. GBT Recent Development
Table 68. FUDA TESTING GROUP Company Information
Table 69. FUDA TESTING GROUP Business Overview
Table 70. FUDA TESTING GROUP Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. FUDA TESTING GROUP Drug and Medical Device Testing Product Portfolio
Table 72. FUDA TESTING GROUP Recent Development
Table 73. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Company Information
Table 74. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Business Overview
Table 75. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
Table 77. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Recent Development
Table 78. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Company Information
Table 79. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Business Overview
Table 80. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Product Portfolio
Table 82. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Recent Development
Table 83. Guangzhou Medicine Industry Research Institute Company Information
Table 84. Guangzhou Medicine Industry Research Institute Business Overview
Table 85. Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Product Portfolio
Table 87. Guangzhou Medicine Industry Research Institute Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Authors List of This Report
Table 90. Secondary Sources
Table 91. Primary Sources
List of Figures
Figure 1. Drug and Medical Device Testing Product Image
Figure 2. Global Drug and Medical Device Testing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Drug and Medical Device Testing Market Size (2021-2032) & (US$ Million)
Figure 4. Global Drug and Medical Device Testing Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Drug Testing Image
Figure 8. Medical Device Testing Image
Figure 9. Global Drug and Medical Device Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Drug and Medical Device Testing Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Drug and Medical Device Testing Sales Value Share by Type (2021-2032)
Figure 12. Pharmaceutical Products Manufacturer Image
Figure 13. Medical Device Manufacturer Image
Figure 14. Global Drug and Medical Device Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Drug and Medical Device Testing Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Drug and Medical Device Testing Sales Value Share by Application (2021-2032)
Figure 17. Global Drug and Medical Device Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 18. Global Drug and Medical Device Testing Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 19. North America Drug and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 20. North America Drug and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 21. Europe Drug and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 22. Europe Drug and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Asia-Pacific Drug and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 24. Asia-Pacific Drug and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 25. South America Drug and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 26. South America Drug and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Middle East & Africa Drug and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 28. Middle East & Africa Drug and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 29. USA Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 30. USA Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 31. USA Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 32. Canada Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. Canada Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. Canada Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Mexico Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Mexico Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Mexico Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Germany Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Germany Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Germany Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. France Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. France Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. France Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. U.K. Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. U.K. Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. U.K. Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. Italy Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. Italy Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. Italy Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Spain Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Spain Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Spain Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Russia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Russia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Russia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Netherlands Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Netherlands Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Netherlands Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Nordic Countries Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Nordic Countries Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. China Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. China Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. China Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Japan Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Japan Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Japan Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. South Korea Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. South Korea Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. South Korea Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. India Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. India Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. India Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. Australia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. Australia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. Australia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Southeast Asia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Southeast Asia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Brazil Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Brazil Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Brazil Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Argentina Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Argentina Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Argentina Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Chile Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Chile Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Chile Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Colombia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Colombia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Colombia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Peru Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Peru Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Peru Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Saudi Arabia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Saudi Arabia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Israel Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Israel Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Israel Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. UAE Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. UAE Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. UAE Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Turkey Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Turkey Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Turkey Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Iran Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Iran Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Iran Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Egypt Drug and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Egypt Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Egypt Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Years Considered
Figure 114. Research Process
Figure 115. Key Executives Interviewed
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Pharmaceutical Products Manufacturer
- Medical Device Manufacturer
Companies covered
- SGS
- Beijing Pony Testing Company
- GTTC
- Shanghai International Certification Assessment Services Co.,Ltd.
- Guangdong Sino-sci Testing Technology Corporation Limited
- GBT
- FUDA TESTING GROUP
- Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
- Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
- Guangzhou Medicine Industry Research Institute
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Drug and Medical Device Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Drug and Medical Device Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Drug and Medical Device Testing Market Dynamics
- 2.1 Drug and Medical Device Testing Industry Trends
- 2.2 Drug and Medical Device Testing Industry Drivers
- 2.3 Drug and Medical Device Testing Industry Opportunities and Challenges
- 2.4 Drug and Medical Device Testing Industry Restraints
3 Drug and Medical Device Testing Market by Company
- 3.1 Global Drug and Medical Device Testing Company Revenue Ranking in 2025
- 3.2 Global Drug and Medical Device Testing Revenue by Company (2021-2026)
- 3.3 Global Drug and Medical Device Testing Company Ranking (2024-2026)
- 3.4 Global Drug and Medical Device Testing Company Manufacturing Base and Headquarters
- 3.5 Global Drug and Medical Device Testing Company Product Type and Application
- 3.6 Global Drug and Medical Device Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Drug and Medical Device Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Drug and Medical Device Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Drug and Medical Device Testing Market by Type
- 4.1 Drug and Medical Device Testing Type Introduction
- 4.1.1 Drug Testing
- 4.1.2 Medical Device Testing
- 4.2 Global Drug and Medical Device Testing Sales Value by Type
- 4.2.1 Global Drug and Medical Device Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Drug and Medical Device Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Drug and Medical Device Testing Sales Value Share by Type (2021-2032)
5 Drug and Medical Device Testing Market by Application
- 5.1 Drug and Medical Device Testing Application Introduction
- 5.1.1 Pharmaceutical Products Manufacturer
- 5.1.2 Medical Device Manufacturer
- 5.2 Global Drug and Medical Device Testing Sales Value by Application
- 5.2.1 Global Drug and Medical Device Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Drug and Medical Device Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Drug and Medical Device Testing Sales Value Share by Application (2021-2032)
6 Drug and Medical Device Testing Regional Value Analysis
- 6.1 Global Drug and Medical Device Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Drug and Medical Device Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Drug and Medical Device Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Drug and Medical Device Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Drug and Medical Device Testing Sales Value (2021-2032)
- 6.3.2 North America Drug and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Drug and Medical Device Testing Sales Value (2021-2032)
- 6.4.2 Europe Drug and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Drug and Medical Device Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Drug and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Drug and Medical Device Testing Sales Value (2021-2032)
- 6.6.2 South America Drug and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Drug and Medical Device Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Drug and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
7 Drug and Medical Device Testing Country-level Value Analysis
- 7.1 Global Drug and Medical Device Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Drug and Medical Device Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Drug and Medical Device Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Drug and Medical Device Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Drug and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Drug and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Drug and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Drug and Medical Device Testing Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 Beijing Pony Testing Company
- 8.2.1 Beijing Pony Testing Company Company Information
- 8.2.2 Beijing Pony Testing Company Business Overview
- 8.2.3 Beijing Pony Testing Company Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Beijing Pony Testing Company Drug and Medical Device Testing Product Portfolio
- 8.2.5 Beijing Pony Testing Company Recent Developments
- 8.3 GTTC
- 8.3.1 GTTC Company Information
- 8.3.2 GTTC Business Overview
- 8.3.3 GTTC Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 GTTC Drug and Medical Device Testing Product Portfolio
- 8.3.5 GTTC Recent Developments
- 8.4 Shanghai International Certification Assessment Services Co.,Ltd.
- 8.4.1 Shanghai International Certification Assessment Services Co.,Ltd. Company Information
- 8.4.2 Shanghai International Certification Assessment Services Co.,Ltd. Business Overview
- 8.4.3 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 8.4.5 Shanghai International Certification Assessment Services Co.,Ltd. Recent Developments
- 8.5 Guangdong Sino-sci Testing Technology Corporation Limited
- 8.5.1 Guangdong Sino-sci Testing Technology Corporation Limited Company Information
- 8.5.2 Guangdong Sino-sci Testing Technology Corporation Limited Business Overview
- 8.5.3 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Product Portfolio
- 8.5.5 Guangdong Sino-sci Testing Technology Corporation Limited Recent Developments
- 8.6 GBT
- 8.6.1 GBT Company Information
- 8.6.2 GBT Business Overview
- 8.6.3 GBT Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 GBT Drug and Medical Device Testing Product Portfolio
- 8.6.5 GBT Recent Developments
- 8.7 FUDA TESTING GROUP
- 8.7.1 FUDA TESTING GROUP Company Information
- 8.7.2 FUDA TESTING GROUP Business Overview
- 8.7.3 FUDA TESTING GROUP Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 FUDA TESTING GROUP Drug and Medical Device Testing Product Portfolio
- 8.7.5 FUDA TESTING GROUP Recent Developments
- 8.8 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
- 8.8.1 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Company Information
- 8.8.2 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Business Overview
- 8.8.3 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 8.8.5 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Recent Developments
- 8.9 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
- 8.9.1 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Company Information
- 8.9.2 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Business Overview
- 8.9.3 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 8.9.5 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Recent Developments
- 8.10 Guangzhou Medicine Industry Research Institute
- 8.10.1 Guangzhou Medicine Industry Research Institute Company Information
- 8.10.2 Guangzhou Medicine Industry Research Institute Business Overview
- 8.10.3 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Product Portfolio
- 8.10.5 Guangzhou Medicine Industry Research Institute Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst